How to consider Trump’s pharma tariffs — earlier than they hit
For weeks, President Trump has made it clear that tariffs are going to be slapped on prescribed drugs. However that’s about the one factor that’s clear.
For the second, his administration has opened a proper investigation that will decide the extent to which importing these merchandise represents a nationwide safety threat — after which resolve the scope of the tariffs and the way they are going to be utilized. In the meantime, the pharmaceutical business, traders, and customers are left questioning what to anticipate — and the way rather more the tariffs might value them.
There are numerous potentialities to unpack, such because the origins of energetic pharmaceutical components and the varieties of medicines extra prone to rise in value than others. There are additionally the maneuvers drug firms could make — from pricing methods to transferring manufacturing round — to be able to mitigate the influence and there may be the extent to which some medicine, specifically generics, might stay accessible.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
